×
S&P 500   3,825.33 (+1.06%)
DOW   31,097.26 (+1.05%)
QQQ   282.13 (+0.66%)
AAPL   138.93 (+1.62%)
MSFT   259.58 (+1.07%)
META   160.03 (-0.76%)
GOOGL   2,174.75 (-0.21%)
AMZN   109.56 (+3.15%)
TSLA   681.79 (+1.24%)
NVDA   145.23 (-4.20%)
NIO   21.36 (-1.66%)
BABA   116.00 (+2.04%)
AMD   73.67 (-3.66%)
MU   53.65 (-2.95%)
CGC   2.81 (-1.40%)
T   21.31 (+1.67%)
GE   63.54 (-0.20%)
F   11.32 (+1.71%)
DIS   96.14 (+1.84%)
AMC   13.53 (-0.15%)
PFE   52.31 (-0.23%)
PYPL   71.40 (+2.23%)
NFLX   179.95 (+2.91%)
S&P 500   3,825.33 (+1.06%)
DOW   31,097.26 (+1.05%)
QQQ   282.13 (+0.66%)
AAPL   138.93 (+1.62%)
MSFT   259.58 (+1.07%)
META   160.03 (-0.76%)
GOOGL   2,174.75 (-0.21%)
AMZN   109.56 (+3.15%)
TSLA   681.79 (+1.24%)
NVDA   145.23 (-4.20%)
NIO   21.36 (-1.66%)
BABA   116.00 (+2.04%)
AMD   73.67 (-3.66%)
MU   53.65 (-2.95%)
CGC   2.81 (-1.40%)
T   21.31 (+1.67%)
GE   63.54 (-0.20%)
F   11.32 (+1.71%)
DIS   96.14 (+1.84%)
AMC   13.53 (-0.15%)
PFE   52.31 (-0.23%)
PYPL   71.40 (+2.23%)
NFLX   179.95 (+2.91%)
S&P 500   3,825.33 (+1.06%)
DOW   31,097.26 (+1.05%)
QQQ   282.13 (+0.66%)
AAPL   138.93 (+1.62%)
MSFT   259.58 (+1.07%)
META   160.03 (-0.76%)
GOOGL   2,174.75 (-0.21%)
AMZN   109.56 (+3.15%)
TSLA   681.79 (+1.24%)
NVDA   145.23 (-4.20%)
NIO   21.36 (-1.66%)
BABA   116.00 (+2.04%)
AMD   73.67 (-3.66%)
MU   53.65 (-2.95%)
CGC   2.81 (-1.40%)
T   21.31 (+1.67%)
GE   63.54 (-0.20%)
F   11.32 (+1.71%)
DIS   96.14 (+1.84%)
AMC   13.53 (-0.15%)
PFE   52.31 (-0.23%)
PYPL   71.40 (+2.23%)
NFLX   179.95 (+2.91%)
S&P 500   3,825.33 (+1.06%)
DOW   31,097.26 (+1.05%)
QQQ   282.13 (+0.66%)
AAPL   138.93 (+1.62%)
MSFT   259.58 (+1.07%)
META   160.03 (-0.76%)
GOOGL   2,174.75 (-0.21%)
AMZN   109.56 (+3.15%)
TSLA   681.79 (+1.24%)
NVDA   145.23 (-4.20%)
NIO   21.36 (-1.66%)
BABA   116.00 (+2.04%)
AMD   73.67 (-3.66%)
MU   53.65 (-2.95%)
CGC   2.81 (-1.40%)
T   21.31 (+1.67%)
GE   63.54 (-0.20%)
F   11.32 (+1.71%)
DIS   96.14 (+1.84%)
AMC   13.53 (-0.15%)
PFE   52.31 (-0.23%)
PYPL   71.40 (+2.23%)
NFLX   179.95 (+2.91%)
NASDAQ:TRNS

Transcat Stock Forecast, Price & News

$56.65
-0.16 (-0.28%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$55.40
$57.05
50-Day Range
$56.81
$76.47
52-Week Range
$55.40
$101.05
Volume
36,160 shs
Average Volume
46,404 shs
Market Capitalization
$427.48 million
P/E Ratio
37.77
Dividend Yield
N/A
Price Target
$82.00

Transcat Stock Forecast (MarketRank)

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
44.7% Upside
$82.00 Price Target
Short Interest
Healthy
1.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$1.26 M Sold Last Quarter
Proj. Earnings Growth
8.75%
From $1.60 to $1.74 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.21 out of 5 stars

Computer And Technology Sector

222nd out of 937 stocks

Instruments To Measure Electricity Industry

3rd out of 10 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive TRNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.

Transcat logo

About Transcat (NASDAQ:TRNS)

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

TRNS Stock News Headlines

Transcat's (NASDAQ:TRNS) Returns Have Hit A Wall
See More Headlines

Industry, Sector and Symbol

Industry
Instruments to measure electricity
Sub-Industry
N/A
Current Symbol
NASDAQ:TRNS
Employees
765
Year Founded
N/A

Company Calendar

Last Earnings
5/23/2022
Today
7/01/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
3/31/2023

Price Target and Rating

Average Stock Price Forecast
$82.00
High Stock Price Forecast
$85.00
Low Stock Price Forecast
$80.00
Forecasted Upside/Downside
+44.7%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
3 Analysts

Profitability

Net Income
$11.38 million
Pretax Margin
6.44%

Debt

Sales & Book Value

Annual Sales
$204.96 million
Cash Flow
$3.05 per share
Book Value
$11.46 per share

Miscellaneous

Free Float
7,048,000
Market Cap
$427.48 million
Optionable
Not Optionable
Beta
0.84














Transcat Frequently Asked Questions

Should I buy or sell Transcat stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Transcat stock.
View analyst ratings for Transcat
or view top-rated stocks.

What is Transcat's stock price forecast for 2022?

3 brokers have issued 1-year price targets for Transcat's shares. Their TRNS stock forecasts range from $80.00 to $85.00. On average, they predict Transcat's stock price to reach $82.00 in the next year. This suggests a possible upside of 44.7% from the stock's current price.
View analysts' price targets for Transcat
or view top-rated stocks among Wall Street analysts.

How has Transcat's stock performed in 2022?

Transcat's stock was trading at $92.43 at the start of the year. Since then, TRNS stock has decreased by 38.7% and is now trading at $56.65.
View the best growth stocks for 2022 here
.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Transcat
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) announced its earnings results on Monday, May, 23rd. The scientific and technical instruments company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.10. The scientific and technical instruments company earned $55.88 million during the quarter, compared to analysts' expectations of $55.18 million. Transcat had a trailing twelve-month return on equity of 15.28% and a net margin of 5.55%.
View Transcat's earnings history
.

Who are Transcat's key executives?

Transcat's management team includes the following people:

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat CEO Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among Transcat's employees.

What other stocks do shareholders of Transcat own?

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $56.65.

How much money does Transcat make?

Transcat (NASDAQ:TRNS) has a market capitalization of $427.48 million and generates $204.96 million in revenue each year. The scientific and technical instruments company earns $11.38 million in net income (profit) each year or $1.50 on an earnings per share basis.

How many employees does Transcat have?

Transcat employs 765 workers across the globe.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The official website for Transcat is www.transcat.com. The scientific and technical instruments company can be reached via phone at (585) 352-7777, via email at [email protected], or via fax at 585-352-1486.

This page (NASDAQ:TRNS) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.